Result Update:Gravita India
Axis Direct
We maintain our BUY recommendation on the stock.
Broker Research reports: Maximum gain potential
for all stocks
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
RESEARCH REPORTS ALERTS
Load latest
Google or static link led you to an intermediate page.
- All Recent
- Upside
- Buy
- Sell
- Recent Upgrades
- Recent Downgrades
- IPO
- Sector Updates
- Most Recent
- Top Upside
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jul 2025 | Gravita |
Axis Direct
|
1661.40 | 2600.00 | 1898.00 (-12.47%) | 56.49 |
Buy
|
||||
| 06 May 2025 | Gravita |
Axis Direct
|
1661.40 | 2600.00 | 1870.80 (-11.19%) | 56.49 |
Buy
|
||||
| 27 Jun 2025 | Praj Industries |
Geojit BNP Paribas
|
389.00 | 608.00 | 500.10 (-22.22%) | 56.30 |
Buy
|
PRAJ INDUSTRIES
Geojit BNP Paribas
Praj Industries Ltd. is a leading biotechnology and engineering firm offering sustainable solutions in bioenergy, water & wastewater treatment, brewery technologies, and high-purity systems for the pharma and biotech sectors. With a global presence in over 100 countries, and four manufacturing...
|
|||
| 14 Jul 2025 | Laxmi Dental |
Motilal Oswal
|
346.60 | 540.00 | 445.90 (-22.27%) | 55.80 |
Buy
|
||||
| 29 Apr 2025 | Patel Engineering |
Ventura
|
40.66 | 63.00 | 44.43 (-8.49%) | 54.94 |
Buy
|
||||
| 12 Aug 2025 | Edelweiss Financial |
Keynote Capitals Ltd
|
119.03 | 184.00 | 94.50 (25.96%) | 54.58 |
Buy
|
||||
| 24 Mar 2025 | Cohance Lifesciences |
BOB Capital Markets Ltd.
|
909.40 | 1405.00 | 1175.50 (-22.64%) | 54.50 |
Buy
|
||||
| 26 May 2025 | Updater Services |
Motilal Oswal
|
259.50 | 400.00 | 340.80 (-23.86%) | 54.14 |
Buy
|
A balanced quarter
Motilal Oswal
Updater Services (UDS) reported a revenue growth of 12% YoY/2% QoQ to INR7.1b, in line with our estimate of ~INR7.1b. Core EBITDA margin came in at 5.0%, down 140bp YoY (vs. est. 6.4%). Consolidated adj. PAT stood at INR342m (up 9% QoQ), above our estimates of INR280m.
|
|||
| 25 Mar 2025 | Cohance Lifesciences |
ICICI Securities Limited
|
909.40 | 1400.00 | 1175.50 (-22.64%) | 53.95 |
Buy
|
A distinct CDMO in the making
ICICI Securities Limited
Suven’s rapid ascendance in the CDMO space has been remarkable. It has journeyed from being a small molecule-focused CDMO to achieving eminence as one of the few CDMOs in India that offers contract manufacturing of oligonucleotides and ADCs.
|
|||
| 28 Jul 2025 | Lodha Developers |
Motilal Oswal
|
1216.10 | 1870.00 | 1203.20 (1.07%) | 53.77 |
Buy
|
Result below est., but presales and BD momentum intact
Motilal Oswal
In 1QFY26, Lodha Developers (LODHA)’s presales were up 10% YoY to INR44.5b (12% below our estimate). Collections rose 7% YoY to INR28.8b (34% below our estimates), and OCF improved 44% YoY to INR9.5b.
|
|||
|
more
loading
|
|||||||||||
* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.